Abstract
Drug-tolerant cancer cell subpopulations are responsible for relapse after chemotherapy. By continuously exposing the gastric cancer cell line MKN45 to 5-FU for >100 passages, we established a 5-fluorouracil (5-FU)-tolerant line, MKN45/5FU. Orthotopic xenografts of MKN45/5FU cells in the stomach of nude mice revealed that these cells had a high potential to metastasize to sites such as the liver. Levels of phosphorylated phosphatidylinositide 3-kinase (PI3K) increased both in 5-FU-tolerant subpopulations according to the 5-FU dose, and in gastric submucosal orthotopic xenografts of MKN45/5FU cells. Sequential administration of 5-FU and a PI3K inhibitor, GDC-0941, targeted the downstream ribosomal S6 kinase phosphorylation to significantly suppress 5-FU-tolerant subpopulations and tumor propagation of orthotopic MKN45/5FU xenografts. These results suggest that administration of 5-FU followed by GDC-0941 may suppress disease relapse after 5-FU-based gastric cancer chemotherapy.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antimetabolites, Antineoplastic / pharmacology*
-
Cell Line, Tumor
-
Cell Proliferation / drug effects
-
Class I Phosphatidylinositol 3-Kinases / antagonists & inhibitors
-
Class I Phosphatidylinositol 3-Kinases / genetics
-
Class I Phosphatidylinositol 3-Kinases / metabolism
-
Codon
-
Disease Models, Animal
-
Dose-Response Relationship, Drug
-
Drug Resistance, Neoplasm / drug effects*
-
Drug Resistance, Neoplasm / genetics
-
Fluorouracil / pharmacology*
-
Genetic Variation
-
Heterografts
-
Humans
-
Mice
-
Neoplasms / genetics
-
Neoplasms / metabolism
-
Neoplasms / pathology
-
Phenotype
-
Phosphatidylinositol 3-Kinases / genetics
-
Phosphatidylinositol 3-Kinases / metabolism
-
Phosphoinositide-3 Kinase Inhibitors*
-
Phosphorylation
-
Proteome
-
Proteomics / methods
-
Ribosomal Protein S6 Kinases, 90-kDa / metabolism
-
Signal Transduction
Substances
-
Antimetabolites, Antineoplastic
-
Codon
-
Phosphoinositide-3 Kinase Inhibitors
-
Proteome
-
Class I Phosphatidylinositol 3-Kinases
-
PIK3CA protein, human
-
Ribosomal Protein S6 Kinases, 90-kDa
-
Fluorouracil